Agilex Biolabs is an Australian contract research organization (CRO) providing bioanalytical services, toxicology, and clinical trial support for pharmaceutical and biotechnology companies.
Subscribe to see Agilex Biolabs’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Agilex Biolabs is a biotechnology & clinical research company headquartered in Australia. Xcout tracks 8 named people at Agilex Biolabs, including Stephen McIntyre (Chief Executive Officer).
2 more named people on record for Agilex Biolabs, with roles, board committees and tenure — see the full roster →
A few of Agilex Biolabs's closest competitors — see the full list of competitors and alternatives →
BioAgilytix is a global leader in bioanalytical services with advanced laboratory facilities located in Durham, North Carolina, alongside European and Australian headquarters to support pharmaceutical and biotech development.
Biotoxtech Co., Ltd. is a South Korean contract research organization that provides nonclinical drug-development services, including toxicology, pharmacology, pharmacokinetics, pathology, and related GLP studies. It serves pharmaceutical and biotechnology companies developing drugs and other biomedical products.
Meadowhawk Biolabs, Inc. is a preclinical contract research organization that provides expert bioanalysis and related research services.
Vivo Bio Tech Limited is an India-based contract research organization that provides preclinical drug-discovery and development services, including in-vivo pharmacology, toxicology, and related bioanalytical work. It serves pharmaceutical and biotechnology companies developing drugs and other healthcare products.
Novotech is a global full-service clinical research organization (CRO) founded in Australia and headquartered in Singapore that drives innovation in drug development.
KABS Laboratories is a Canadian contract research organization serving pharmaceutical and biotechnology companies. It provides drug-development support including bioequivalence and bioavailability studies, pharmacokinetic research, clinical services, and analytical laboratory testing.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.